• Navigating Regulatory Challenges and Ensuring Safety in the Psychedelics Industry

  • Aug 26 2023
  • Durée: 55 min
  • Podcast
Page de couverture de Navigating Regulatory Challenges and Ensuring Safety in the Psychedelics Industry

Navigating Regulatory Challenges and Ensuring Safety in the Psychedelics Industry

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • "Balancing Medical Promise and Regulatory Complexity in the Psychedelics Landscape"

    The "Psychedelics Capital Podcast" host Ross O'Brien  from Bonaventure Equity interviews Michael Werner from Holland & Knight, discussing the regulatory landscape for psychedelics. Michael, a partner at the law firm, explains that while the FDA sees itself as a public health agency focused on ensuring safe and effective products, the DEA approaches controlled substances like psychedelics from a law enforcement perspective due to their potential dangers. He highlights that while many drugs, including psychedelics, have potential benefits, the FDA emphasizes the importance of rigorous clinical trials to establish their safety and efficacy, particularly in a landscape where recreational and unregulated use is also prevalent.

     

    Produced by PodConx

    Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

    Bonaventure Equity - https://link.bve.vc/Visit-Us

    Michael Warner - https://www.linkedin.com/in/michael-werner-a402189/

    Holland & Knight - https://www.hklaw.com/
    Voir plus Voir moins
Voir plus Voir moins

Ce que les auditeurs disent de Navigating Regulatory Challenges and Ensuring Safety in the Psychedelics Industry

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.